These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9035130)

  • 1. Reflections on internal images.
    Greenspan NS
    Nat Biotechnol; 1997 Feb; 15(2):123-4. PubMed ID: 9035130
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
    Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
    Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of anti-toxin antibodies by immunization with Pichia killer toxin-like antiidiotypic monoclonal antibodies.
    Snyder C; Seguy N; Lafitte S; Guyard C; Polonelli L; Cailliez JC; Grzych JM
    J Eukaryot Microbiol; 1999; 46(5):138S. PubMed ID: 10519290
    [No Abstract]   [Full Text] [Related]  

  • 4. Killer anti-idiotypes in the control of fungal infections.
    Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
    Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxin.
    Séguy N; Aliouat EM; Dei-Cas E; Polonelli L; Camus D; Cailliez JC
    J Eukaryot Microbiol; 1994; 41(5):109S. PubMed ID: 7804202
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.
    Magliani W; Conti S; Salati A; Vaccari S; Ravanetti L; Maffei DL; Polonelli L
    FEMS Yeast Res; 2004 Oct; 5(1):11-8. PubMed ID: 15381118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro decrease of rat-derived Pneumocystis carinii attachment induced by human natural yeast killer toxin-like antiidiotypic candidacidal antibodies.
    Séguy N; Polonelli L; Conti S; Dei-Cas E; Camus D; Cailliez JC
    J Eukaryot Microbiol; 1996; 43(5):27S. PubMed ID: 8822831
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis.
    Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
    FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical importance of yeast killer toxin].
    Cerikcioğlu N
    Mikrobiyol Bul; 2003; 37(2-3):215-21. PubMed ID: 14593905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From yeast killer toxins to antibiobodies and beyond.
    Magliani W; Conti S; Travassos LR; Polonelli L
    FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human natural yeast killer toxin-like candidacidal antibodies.
    Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
    J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
    Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
    Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transphyletic anti-infectious control strategy based on the killer phenomenon.
    Conti S; Magliani W; Gerloni M; Salati A; Dieci E; Arseni S; Fisicaro P; Polonelli L
    FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):151-61. PubMed ID: 9792074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.
    Polonelli L; Séguy N; Conti S; Gerloni M; Bertolotti D; Cantelli C; Magliani W; Cailliez JC
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):142-6. PubMed ID: 9067647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of a Pichia anomala killer toxin on Pneumocystis carinii infectivity to the SCID mouse.
    Séguy N; Cailliez JC; Polonelli L; Dei-Cas E; Camus D
    Parasitol Res; 1996; 82(2):114-6. PubMed ID: 8825204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer antibodies in fungal infections.
    Conti S; Magliani W; Fisicaro P; Dieci E; Arseni S; Salati A; Polonelli L
    Res Immunol; 1998; 149(4-5):334-43; discussion 523. PubMed ID: 9720951
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory effect of a Pichia anomala killer toxin on the viability of rat-derived Pneumocystis carinii.
    Jackson HC; Séguy N; Killigin EM; Dei-Cas E; Polonelli L; Cailliez JC
    J Eukaryot Microbiol; 1996; 43(5):29S. PubMed ID: 8822833
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal killer toxin-like antiidiotypic antibodies to control rat-pneumocystosis.
    Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
    J Eukaryot Microbiol; 1997; 44(6):37S. PubMed ID: 9508425
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis.
    Travassos LR; Silva LS; Rodrigues EG; Conti S; Salati A; Magliani W; Polonelli L
    J Antimicrob Chemother; 2004 Nov; 54(5):956-8. PubMed ID: 15448128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Aspergillus ribonucleolytic toxins (ribotoxins).
    Lamy B; Davies J; Schindler D
    Targeted Diagn Ther; 1992; 7():237-58. PubMed ID: 1633293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.